Literature DB >> 9951519

[Erectile function after treatment of prostatic carcinoma].

H Lindner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9951519     DOI： 10.1007/BF02743463

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  6 in total

1.  Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

Authors:  I Goldstein; T F Lue; H Padma-Nathan; R C Rosen; W D Steers; P A Wicker
Journal:  N Engl J Med       Date:  1998-05-14       Impact factor: 91.245

2.  Quality of life and treatment outcomes: prostate carcinoma patients' perspectives after prostatectomy or radiation therapy.

Authors:  C L Shrader-Bogen; J L Kjellberg; C P McPherson; C L Murray
Journal:  Cancer       Date:  1997-05-15       Impact factor: 6.860

3.  Erectile functioning of men treated for prostate carcinoma.

Authors:  J W Robinson; M S Dufour; T S Fung
Journal:  Cancer       Date:  1997-02-01       Impact factor: 6.860

4.  Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer.

Authors:  M J Zelefsky; J F Eid
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

5.  A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team.

Authors:  C Fleming; J H Wasson; P C Albertsen; M J Barry; J E Wennberg
Journal:  JAMA       Date:  1993-05-26       Impact factor: 56.272

Review 6.  A structured literature review of treatment for localized prostate cancer. Prostate Disease Patient Outcome Research Team.

Authors:  J H Wasson; C C Cushman; R C Bruskewitz; B Littenberg; A G Mulley; J E Wennberg
Journal:  Arch Fam Med       Date:  1993-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.